PSI VisSIG Wonderful Wednesday Webinar Series
This is a good opportunity to develop your knowledge by thinking through a practical example, practicing how to apply graphics principles, and developing your coding skills.
When autocomplete results are available use up and down arrows to review and enter to select.
menu
menu
Statistical Excellence in the Pharmaceutical Industry Award
Our award for statistical excellence in the pharmaceutical industry is made jointly with the Royal Statistician Society (RSS) every year.
The aim of the award is to recognise an outstanding level of influence in the application of an existing statistical practice, or an innovation, that has strengthened the quality and efficiency of investigations in the pharmaceutical industry.
Read about last year's winner here.
Criteria
We are looking for entries that have demonstrated one or more of the following:
- A clear understanding of the needs of researchers and investigators
- An application of an existing statistical practice to a new area that has increased the quality and efficiency of investigations
- A new development in the design of investigations and/or the analysis of data that has led to further insights into the safety, efficacy and value of medicines or devices
- An excellent way to communicate results that is clear and helpful to a wide array of users, showing how statisticians understand the range of user needs
Nominees can be based anywhere in the world and do not need to be a member of PSI or the RSS. The award will be presented at the annual PSI AGM.
Statistical Excellence - Previous Winners
2015 Award
Katrina Gore and Nicky Best (joint winners, 2015, Pfizer and GSK respectively). Katrina Gore for her work on the Assay Capability Tool (ACT), designed to guide the development of drug discovery assays. Nicky Best for her work implementing a process that has turned beliefs about the chances of success into formal prior distributions.
2016 Award
Richard Nixon of Novartis was presented with the award in 2016 for “Enhancing decision-making in drug development using quantitative approaches’.
2017 Award
The 2017 award was presented to Michael O'Kelly for his work 'Promoting analytical solutions and best practices for handling missing data in pharmaceutical industry'. The judges felt that in this respect, he has made a major contribution to enhancing the practical application of modelling and simulation methodology and tools for analysing data with missing values.
2018 Award
The 2018 award was jointly presented to Dr. Mouna Akacha (Novartis) for “Enhancing drug development using clinically interpretable treatment effect measures (‘estimands‘) that allow for efficient statistical analyses” and Dr. Simon Bate for “Improving the quality and reliability of animal research through the use of InVivoStat: a statistical software package for animal researchers”.
2019 Award
The 2019 award was jointly presented to Mike Smith (Pfizer) for his work on ‘Excellence in research around population modelling in drug development’ and its ‘pioneering practical Bayesian methods with drug development in the context of optimising decision making within trials and modelling dose response with pharmacokinetic/pharmacodynamic modelling’ and Graeme Archer and Jacquie Christie (GSK) for their work on ‘Quantitative Decision-Making for clinical development’, which was deemed to be ‘at the cutting edge of revolutionising data driven decision making within the industry’.
2020 Award
The 2020 award was presented to Dr. Sandeep M Menon, Senior Vice President and Head of Early Clinical Development at Pfizer, for “Influential Quantitative Leadership in several domains in Early Clinical Development - creating a culture of quantitative decision making within a major pharmaceutical company.” The judging panel found Dr Menon’s work to be an impressive demonstration of the value of biostatistics as well as an effective promotion of statistical thinking within a large organisation. Tim Rolfe, chair of the PSI award committee said “Dr Menon is a well deserving winner of this year's award. His impact as an innovative statistical leader shone through-out the successful nomination.”
2021 Award
Lisa Hampson was presented with the PSI / RSS Award for Statistical Excellence in the Pharmaceutical Industry. She was nominated for her work on: "Improving the assessment of the probability of success in drug development: A holistic framework encompassing statistical significance, regulatory approval, and market access". Distinguishing it from existing approaches, this framework adopts a broader definition of ‘success’ that bridges statistical significance, clinical relevance, benefit-risk assessments, regulatory alignment, and market access as well as technical development, quality and compliance considerations.
This approach was endorsed by the Novartis Innovation Management Board, chaired by the company’s CEO, in September 2020 and has since then formally been rolled out across the entire portfolio.
Upcoming Events
PSI Careers Lunch & Learn: Pharma-ly Fortunes
The upcoming event - "Pharma-ly Fortunes" - will involve playing along to a Family Fortunes style survey - it promises to be a fun but informative session where we hear from our experienced panel on wide ranging career-related topics. We may even debunk some popular myths!
PSI Journal Club: Biomarker Adaptive Designs
The DIA Statistics and Data Science Virtual Journal Club are pleased to announce a joint webinar with the Statisticians in the Pharmaceutical Industry (PSI) journal club. The title is Biomarker Adaptive Designs.
PSI Mentoring
Are you a member of PSI looking to further your career or help develop others - why not sign up to the PSI Mentoring scheme? You can expand your network, improve your leadership skills and learn from more senior colleagues in the industry. Mentors and mentees will be matched based on experience, personal goals and the sector they work in (unless otherwise requested) so you can be assured that we will aim to tailor the experience to your needs.
PSI VisSIG Wonderful Wednesday Webinar Series (2023)
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI Biomarkers SIG Webinar: Biomarkers in Clinical Development
In this webinar, you will learn more about recent advances in biomarker-based designs, machine learning for biomarkers and data repositories for biomarker use cases.
PSI Scientific Meeting: Decentralised Clinical Trials
In this event we will hear from expert speakers on the statistical and operational challenges and considerations of decentralised clinical trials, the promise of digital health data and wearable technology, as well the regulatory perspective to such studies
Latest Jobs
Apprentice Biostatistician
The Apprentice Biostatistician splits their time between working for Parexel and performing studies with a university to obtain a MSc in Statistics over a period of three years.
Manager Statistical Programming (m/f/x)
For our headquarters in Munich we are seeking highly qualified candidates to apply for Manager Statistical Programming (m/f/x).
Statisticians in the Pharmaceutical Industry Executive Office:
c/o MCI UK | Building 1000 | Western Road | Portsmouth | Hampshire | PO6 3EZ | UK
c/o MCI UK | Building 1000 | Western Road | Portsmouth | Hampshire | PO6 3EZ | UK
E: PSI@mci-group.com | T: +44 (0)1730 715 235